(Q38179563)

30 August 2017

Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? (English)

1 reference

30 August 2017

0 references

S Bertel Squire

5

0 references

Keertan Dheda

6

object named as

Keertan Dheda

1 reference

30 August 2017

Grant Theron

1

1 reference

30 August 2017

Jonny Peter

2

1 reference

30 August 2017

David Dowdy

3

1 reference

30 August 2017

Ivor Langley

4

1 reference

30 August 2017

15 January 2014

1 reference

Lancet Infectious Diseases

30 August 2017

1 reference

30 August 2017

14

1 reference

30 August 2017

527-532

1 reference

30 August 2017

6

1 reference

Point-of-care diagnosis of tuberculosis: past, present and future

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Reducing the global burden of tuberculosis: the contribution of improved diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Performance of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings: a multisite study in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Performance of an algorithm based on WHO recommendations for the diagnosis of smear-negative pulmonary tuberculosis in patients without HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Validation in Uganda of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Evaluation of the World Health Organization algorithm for the diagnosis of HIV-associated sputum smear-negative tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Supervised and induced sputum among patients with smear-negative pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Modelling the impacts of new diagnostic tools for tuberculosis in developing countries to enhance policy decisions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970360-8

7 January 2021

10.1016/S1473-3099(13)70360-8

Identifiers

DOI

1 reference

30 August 2017

1 reference